Glucose availability enhances lipopolysaccharide production and immunogenicity in the opportunistic pathogen Acinetobacter baumannii

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 McConnell MJ, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol. Rev. 37, 130–155 (2013).
  Medline CASGoogle Scholar
• 2 Valencia R, Arroyo LA, Conde M et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect. Control Hosp. Epidemiol. 30, 257–263 (2009).
  MedlineGoogle Scholar
• 3 Vila J, Pachón J. Therapeutic options for Acinetobacter baumannii infections: an update. Expert. Opin. Pharmacother. 13, 2319–2336 (2012).
  Medline CASGoogle Scholar
• 4 Dexter C, Murray GL, Paulsen IT, Peleg AY. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert. Rev. Anti Infect. Ther. 13, 567–573 (2015).
  Medline CASGoogle Scholar
• 5 Choi CH, Lee EY, Lee YC et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol. 7, 1127–1138 (2005).
  Medline CASGoogle Scholar
• 6 Jin JS, Kwon SO, Moon DC et al. Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS ONE 6, e17027 (2011). •• Describes the mechanism of outer membrane vesicle-mediated secretion of the cytotoxic protein OmpA in Acinetobacter baumannii.
  Medline CASGoogle Scholar
• 7 Luke NR, Sauberan SL, Russo TA et al. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect. Immun. 78, 2017–2023 (2010). •• Identifies a glycosyltransferase involved in lipopolysaccharide biosynthesis and shows that truncations in the lipopolysaccharide molecule increases A. baumannii sensitivity to serum killing and confers competitive advantage for survival in vivo.
  Medline CASGoogle Scholar
• 8 Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J. Clin. Microbiol. 36, 1938–1941 (1998).
  Medline CASGoogle Scholar
• 9 Fiester SE, Actis LA. Stress responses in the opportunistic pathogen Acinetobacter baumannii. Future Microbiol. 8, 353–365 (2013).
  CASGoogle Scholar
• 10 Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977–2000. Infect. Control Hosp. Epidemiol. 24, 284–295 (2003).
  MedlineGoogle Scholar
• 11 Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 4, 273–278 (2009). •• This manuscript is a very extensive review of biofilm regulation in A. baumannii in the context of its pathogenicity and its ability to persist in nosocomial settings.
  CASGoogle Scholar
• 12 Lee HW, Koh YM, Kim J et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 14, 49–54 (2008).
  Medline CASGoogle Scholar
• 13 Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J. Bacteriol. 191, 5953–5963 (2009).
  Medline CASGoogle Scholar
• 14 Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149, 3473–3484 (2003).
  Medline CASGoogle Scholar
• 15 Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J. Bacteriol. 190, 1036–1044 (2008).
  Medline CASGoogle Scholar
• 16 Russo TA, Luke NR, Beanan JM et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307–0294 is a major virulence factor. Infect. Immun. 78, 3993–4000 (2010).
  Medline CASGoogle Scholar
• 17 Marti S, Nait Chabane Y, Alexandre S et al. Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors. PLoS ONE 6, e26030 (2011).
  Medline CASGoogle Scholar
• 18 Freckmann G, Hagenlocher S, Baumstark A et al. Continuous glucose profiles in healthy subjects under everyday life conditions and after different meals. J. Diabetes Sci. Technol. 1, 695–703 (2007).
  MedlineGoogle Scholar
• 19 Thennadil SN, Rennert JL, Wenzel BJ, Hazen KH, Ruchti TL, Block MB. Comparison of glucose concentration in interstitial fluid, and capillary and venous blood during rapid changes in blood glucose levels. Diabetes Technol. Ther. 3, 357–365 (2001).
  Medline CASGoogle Scholar
• 20 Daddaoua A, Molina-Santiago C, de la Torre J, Krell T, Ramos JL. GtrS and GltR form a two-component system: the central role of 2-ketogluconate in the expression of exotoxin A and glucose catabolic enzymes in Pseudomonas aeruginosa. Nucleic Acids Res. 42, 7654–7663 (2014).
  Medline CASGoogle Scholar
• 21 Munson GP. Virulence regulons of enterotoxigenic Escherichia coli. Immunol. Res. 57, 229–236 (2013).
  Medline CASGoogle Scholar
• 22 Zarrilli R, Giannouli M, Rocco F et al. Genome sequences of three Acinetobacter baumannii strains assigned to the multilocus sequence typing genotypes ST2, ST25, and ST78. J. Bacteriol. 193, 2359–2360 (2011). • Reports the genomic sequence of the clinical isolate of A. baumannii studied in this work.
  Medline CASGoogle Scholar
• 23 Dorel C, Vidal O, Prigent-Combaret C, Vallet I, Lejeune P. Involvement of the Cpx signal transduction pathway of E. coli in biofilm formation. FEMS Microbiol. Lett. 178, 169–175 (1999).
  Medline CASGoogle Scholar
• 24 Nucleo E, Steffanoni L, Fugazza G et al. Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol. 22, 9–270 (2009). • Describes the phenotypic characteristic of the clinical isolate of A. baumannii studied in this work.
  Google Scholar
• 25 Spaink HP, Okker RJH, Wijffelman CA, Pees E, Lugtenberg BJJ. Promoters in the nodulation region of the Rhizobium leguminosarum Sym plasmid pRL1J1. Plant. Mol. Biol. 9, 27–39 (1987).
  Medline CASGoogle Scholar
• 26 Peano C, Chiaramonte F, Motta S et al. Gene and protein expression in response to different growth temperatures and oxygen availability in Burkholderia thailandensis. PLoS ONE 9, e93009 (2014).
  MedlineGoogle Scholar
• 27 Goldberg JB, Ohman DE. Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate. J. Bacteriol. 158, 1115–1121 (1984).
  Medline CASGoogle Scholar
• 28 Miller JH. Experiments In Molecular Genetics. Cold Spring Harbor Laboratory Press, NY, USA (1972).
  Google Scholar
• 29 Antunes LC, Imperi F, Carattoli A, Visca P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS ONE 6, e22674 (2011). • Compares production of virulence factors in and shows that several A. baumannii isolates possess weak hemolytic activity.
  Medline CASGoogle Scholar
• 30 Blocker A, Gounon P, Larquet E et al. The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes. J. Cell. Biol. 147, 683–693 (1999).
  Medline CASGoogle Scholar
• 31 Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350–356 (1956).
  CASGoogle Scholar
• 32 Marolda CL, Lahiry P, Vinés E, Saldías S, Valvano MA. Micromethods for the characterization of lipid A-core and O-antigen lipopolysaccharide. Methods Mol. Biol. 347, 237–252 (2006).
  Medline CASGoogle Scholar
• 33 Maskell JP. The resolution of bacteroides lipopolysaccharides by polyacrylamide gel electrophoresis. J. Med. Microbiol. 34, 253–257 (1991).
  Medline CASGoogle Scholar
• 34 Reuhs BL, Carlson RW, Kim JS. Rhizobium fredii and Rhizobium meliloti produce 3-deoxy-D-manno-2-octulosonic acid-containing polysaccharides that are structurally analogous to group II K antigens (capsular polysaccharides) found in Escherichia coli. J. Bacteriol. 175, 3570–3580 (1993).
  Medline CASGoogle Scholar
• 35 Moalli F, Doni A, Deban L et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 116, 5170–5180 (2010).
  Medline CASGoogle Scholar
• 36 R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2015). https://www.R-project.org/.
  Google Scholar
• 37 Muller LM, Gorter KJ, Hak E et al. Increased risk of common infections in patients with Type 1 and Type 2 diabetes mellitus. Clin. Infect. Dis. 41, 281–288 (2005).
  Medline CASGoogle Scholar
• 38 Patric. https://www.patricbrc.org/.
  Google Scholar
• 39 Cox RA. Quantitative relationships for specific growth rates and macromolecular compositions of Mycobacterium tuberculosis, Streptomyces coelicolor A3 (2) and Escherichia coli B/r: an integrative theoretical approach. Microbiology 150, 1413–1426 (2004).
  Medline CASGoogle Scholar
• 40 Cabral MP, Soares NC, Aranda J et al. Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J. Proteome Res. 10, 3399–3417 (2011). • Shows that overproduction of proteins involved in sugar utilization such as the Leloir pathway occurs in A. baumannii biofilms and is connected with extracellular polysaccharide production.
  Medline CASGoogle Scholar
• 41 Tayabali AF, Nguyen KC, Shwed PS, Crosthwait J, Coleman G, Seligy VL. Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources. PLoS ONE 7, e37024 (2012).
  Medline CASGoogle Scholar
• 42 Villa F, Remelli W, Forlani F, Gambino M, Landini P, Cappitelli F. Effects of chronic sub-lethal oxidative stress on biofilm formation by Azotobacter vinelandii. Biofouling 28, 823–833 (2012).
  Medline CASGoogle Scholar
• 43 Fregolino E, Gargiulo V, Lanzetta R, Parrilli M, Holst O, Castro CD. Identification and structural determination of the capsular polysaccharides from two Acinetobacter baumannii clinical isolates, MG1 and SMAL. Carbohydr. Res. 346(7), 973–977 (2011).
  Medline CASGoogle Scholar
• 44 Kenyon JJ, Holt KE, Pickard D, Dougan G, Hall RM. Insertions in the OCL1 locus of Acinetobacter baumannii lead to shortened lipooligosaccharides. Res. Microbiol. 165(6), 472–475 (2014).
  Medline CASGoogle Scholar
• 45 Kenyon JJ, Nigro SJ, Hall RM. Variation in the OC Locus of Acinetobacter baumannii genomes predicts extensive structural diversity in the Lipooligosaccharide. PLoS ONE 9(9), e107833 (2014).
  MedlineGoogle Scholar
• 46 Mattsby-Baltzer I, Lindgren K, Lindholm B, Edebo L. Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity. Infect. Immun. 59, 689–695 (1991).
  Medline CASGoogle Scholar
• 47 Beveridge TJ. Structures of Gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181, 4725–4733 (1999).
  Medline CASGoogle Scholar
• 48 Li ZT, Zhang RL, Bi XG et al. Outer membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristics. Microb. Pathog. 81, 46–52 (2015).
  Medline CASGoogle Scholar
• 49 Jun SH, Lee JH, Kim BR et al. Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins. PLoS ONE 8, e71751 (2013).
  Medline CASGoogle Scholar
• 50 Bleumink-Pluym NM, van Alphen LB, Bouwman LI, Wösten MM, van Putten JP. Identification of a functional type VI secretion system in Campylobacter jejuni conferring capsule polysaccharide sensitive cytotoxicity. PLoS Pathog. 9, e1003393 (2013).
  Medline CASGoogle Scholar
• 51 Weber BS, Miyata ST, Iwashkiw JA et al. Genomic and functional analysis of the type VI secretion system in Acinetobacter. PLoS ONE 8, e55142 (2013).
  Medline CASGoogle Scholar
• 52 Carruthers MD, Nicholson PA, Tracy EN, Munson RS Jr. Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS ONE 8, e59388 (2013).
  Medline CASGoogle Scholar
• 53 Ciznár I, Shands JW Jr. Effect of alkali-treated lipopolysaccharide on erythrocyte membrane stability. Infect. Immun. 4, 362–367 (1971).
  Medline CASGoogle Scholar
• 54 Carr C Jr, Morrison DC. Mechanism of polymyxin B-mediated lysis of lipopolysaccharide-treated erythrocytes. Infect. Immun. 49, 84–89 (1985).
  Medline CASGoogle Scholar
• 55 Poole K, Braun V. Influence of growth temperature and lipopolysaccharide on hemolytic activity of Serratia marcescens. J. Bacteriol. 170, 5146–5152 (1988).
  Medline CASGoogle Scholar